Ken Griffin acquired 4.5 Thousand CytomX Therapeutics shares worth $8.51 Thousand. That's 0.00% of their equity portfolio (4904th largest holding). The first CytomX Therapeutics trade was made in Q1 2017. Since then Ken Griffin bought shares 24 more times and sold shares on 26 occasions. The stake costed the investor $7.93 Thousand, netting the investor a gain of 7.3% so far.